227 related articles for article (PubMed ID: 24902987)
1. Possible patterns of epidermal melanocyte disappearance in nonsegmental vitiligo: a clinicopathological study.
Benzekri L; Hmamouchi I; Gauthier Y
Br J Dermatol; 2015 Feb; 172(2):331-6. PubMed ID: 24902987
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo.
Benzekri L; Gauthier Y; Hamada S; Hassam B
Br J Dermatol; 2013 Feb; 168(2):265-71. PubMed ID: 22963656
[TBL] [Abstract][Full Text] [Related]
3. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
4. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
6. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
Gauthier Y; Cario Andre M; Taïeb A
Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
[TBL] [Abstract][Full Text] [Related]
7. Depigmentation patterns of nonsegmental vitiligo: a prospective study of macromorphologic changes in lesions.
Menchini G; Comacchi C; Cappugi P; Torchia D
Am J Clin Dermatol; 2013 Feb; 14(1):55-9. PubMed ID: 23329080
[TBL] [Abstract][Full Text] [Related]
8. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A
Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601
[TBL] [Abstract][Full Text] [Related]
9. Follicular vitiligo: A report of 8 cases.
Gan EY; Cario-André M; Pain C; Goussot JF; Taïeb A; Seneschal J; Ezzedine K
J Am Acad Dermatol; 2016 Jun; 74(6):1178-84. PubMed ID: 26830867
[TBL] [Abstract][Full Text] [Related]
10. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
[TBL] [Abstract][Full Text] [Related]
11. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
[TBL] [Abstract][Full Text] [Related]
12. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
13. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
Garbelli S; Mantovani S; Palermo B; Giachino C
Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
Seleit I; Bakry OA; Abdou AG; Dawoud NM
Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
[TBL] [Abstract][Full Text] [Related]
15. Clinical markers of vitiligo activity.
Benzekri L; Gauthier Y
J Am Acad Dermatol; 2017 May; 76(5):856-862. PubMed ID: 28245942
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
17. Melanocyte reservoir in vitiligo.
Arrunátegui A; Arroyo C; Garcia L; Covelli C; Escobar C; Carrascal E; Falabella R
Int J Dermatol; 1994 Jul; 33(7):484-7. PubMed ID: 7928031
[TBL] [Abstract][Full Text] [Related]
18. Water Buffalo (Bubalus bubalis) as a spontaneous animal model of Vitiligo.
Singh VP; Motiani RK; Singh A; Malik G; Aggarwal R; Pratap K; Wani MR; Gokhale SB; Natarajan VT; Gokhale RS
Pigment Cell Melanoma Res; 2016 Jul; 29(4):465-9. PubMed ID: 27124831
[TBL] [Abstract][Full Text] [Related]
19. Melanocytorrhagy and apoptosis in vitiligo: connecting jigsaw pieces.
Kumar R; Parsad D
Indian J Dermatol Venereol Leprol; 2012; 78(1):19-23. PubMed ID: 22199056
[TBL] [Abstract][Full Text] [Related]
20. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
